Education Program for Enhancing Healthcare Students' Attitudes Toward People Living With Dementia
Launched by UNIVERSITAS AIRLANGGA · Nov 2, 2023
Trial Information
Current as of October 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The clinical trial titled "Education Program for Enhancing Healthcare Students' Attitudes Toward People Living With Dementia" is exploring how a special educational program using gaming can improve healthcare students' feelings and understanding towards individuals with dementia. The program will last about 90 minutes and includes a mix of lectures, interactive gaming activities, and short dramas that illustrate different experiences related to dementia. The study aims to see if participating in this program changes students' attitudes, their willingness to help those with dementia, and their overall knowledge about the condition.
To participate in this trial, healthcare students who are currently enrolled in specific courses related to dementia will be eligible. Participants will have the opportunity to join the program once, gaining valuable insights and skills that can help them in their future careers. This trial is not yet recruiting participants, but it seeks to make a meaningful impact on how future healthcare providers connect with and support people living with dementia.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Healthcare students enrolled in the designated semester and courses that align with the program's implementation
- • Exclusion Criteria: -
About Universitas Airlangga
Universitas Airlangga, a prestigious institution located in Surabaya, Indonesia, is dedicated to advancing medical research and education. As a clinical trial sponsor, the university leverages its strong academic foundation and commitment to innovation to conduct rigorous and ethical clinical studies. With a focus on improving healthcare outcomes, Universitas Airlangga collaborates with various stakeholders, including healthcare professionals and industry partners, to explore new therapies and enhance patient care. Their research initiatives are aligned with global standards, ensuring the integrity and reliability of their findings in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Dianis Wulan Sari, Ph.D
Principal Investigator
Universitas Airlangga
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported